X-linked Hypophosphatemia and FGF21

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions
X-linked Hypophosphatemia
Interventions
OTHER

Descriptive study

Description of the circulating values of Fibroblast Growth Factor 21 in X-linked hypophosphatemia children compared to controls in the VITADOS cohort (healthy children and adolescents aged 10-18 years), after age-matched, pubertal stage and sex).

Trial Locations (3)

31059

Endocrinologie, Maladies Osseuses, Gynécologie, Génétique, Hôpital des Enfants, CHU de Toulouse, Toulouse

69677

Centre de Référence des Maladies Rénales Rares - Centre de Référence des Maladies Rares du Calcium et du Phosphate - Service de Néphrologie, Rhumatologie et Dermatologie Pédiatriques - Hôpital Femme Mère Enfant, Bron

94270

Centre de Référence des Maladies Rares du Calcium et du Phosphore, Service d'Endocrinologie Pédiatrique - Hôpital du Kremlin Bicêtre, Paris

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03596554 - X-linked Hypophosphatemia and FGF21 | Biotech Hunter | Biotech Hunter